- Overview
- Features Insight
- Download
- Video
MyLab™Eight eXP and MyLab™Eight:
MPowered eXPerience in Ultrasound
The New Flasgship Platform in Esaote's Ultrasound Portfolio
Esaote MyLab™Eight eXP and MyLab™Eight Ultrasound systems define a new standard in Image Quality for confident diagnosis.
MyLab™Eight Platform is the culmination of Esaote’s commitment to R&D in order to meet the increasing demands of modern healthcare in terms of outstanding image quality and ease of use, representing the complete solution for the most demanding clinical activity
Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries. Product images are for illustrative purposes only. For further details, please contact your Esaote sales representative.
MyLab™Eight Platform: advanced technologies to meet most demanding requirements
Advanced hemodynamic evaluation tools such as XFlow and HD CFM, quantitative tissue stiffness evaluation with QElaXto, and Virtual Navigator for easy-to-perform real-time fusion imaging are just a few examples of Esaote’s advanced technologies that are tailored to meet all requirements, including the most demanding. Esaote’s focus on the prevention of work-related musculoskeletal disorders runs through MyLabRemote, the remote system user interface app that allows MyLab™Eight eXP and MyLab™Eight to be controlled via smartphone or tablet.
Virtual biopsy technology is a valuable tool for facilitating needle insertions for difficult biopsies and for percutaneous treatments. Other highlights include top-level Contrast Enhanced Ultrasound (CnTI™) and advanced cardiovascular tools, such as the XStrain™ cardiac deformation analysis tool and the radiofrequency-based Intima Media Thickness (QIMT) and Arterial Stiffness (QAS) measurement, underlining Esaote’s trademark “Creativity in Healthcare.”
Esaote's Advanced Technologies
- MyLabRemote: Remote system user interface app that allows MyLab™Eight Platform to be controlled via smartphone or tablet.
- ElaXto: Full Strain Elastosonography package for multiple applications. Full measurement package, available on many probe typologies.
- CnTI™ Contrast Tuned Imaging: Esaote’s proprietary CnTI™ provides high performance contrast enhanced ultrasound imaging with second generation contrast media.
- BodyMap: 2D Navigation technology on second imaging modality, Body mark and patient examined area picture.
- Virtual Biopsy: Advanced Biopsy also in very difficult approaches: Virtual Biopsy allows physicians to follow percutaneous procedures by superimposing needle tracking information on the real-time ultrasound image.
- Virtual Navigator: Advanced tool for Multimodality Real-time Fusion Imaging.
>> GET ACCESS AND ENJOY VIRTUAL NAVIGATOR APP
Radiology
Advanced Diagnostic Tools:
- CnTI™ Full spectrum Contrast enhanced ultrasound
- ElaXto Full Strain Elastosonography package for multiple applications
- QElaXto Shear Wave Tissue Stiffness Quantitative Assessment (MyLab™Eight eXP only)
- Virtual Biopsy Clear visualization of needle insertion and path
- Virtual Navigator State of the Art Real-time Multiple modality Fusion Imaging Technology
Large selection of probes:
- C 1-8 Single Crystal convex array probes for Difficult-to-scan patients
- L 4-15 High Frequency Linear array probe for optimized spatial and contrast image resolution
- Linear array probes from 3 to 22 MHz
- Biopsy dedicated Convex probe with 0°, 5°, 15° needle insertion angle
- IH 6-18 High Frequency Hockey Stick probe
- TRT33 Transrectal Dual array and Endocavity probes
Interventional and Surgery
Advanced Diagnostic Tools:
- Virtual Biopsy Clear visualization of needle insertion and path
- Virtual Navigator State of the Art Real-time Multiple modality Fusion Imaging Technology
- CnTI™ Full spectrum Contrast enhanced ultrasound (available also during Fusion Imaging)
- ElaXto Full Strain Elastosonography package for multiple applications (also in Fusion Imaging)
- QElaXto Shear Wave Tissue Stiffness Quantitative Assessment (MyLab™Eight eXP only) - (available also during Fusion Imaging)
Large selection of probes:
- C 1-8 Single Crystal convex array probes for Difficult-to-scan patients
- Biopsy dedicated Convex probe with 0°, 5°, 15° needle insertion angle
- TRT33 Transrectal Dual array and Endocavity probes with Transperineal biopsy kit
- Linear, Convex, 3D Convex, Microconvex probes with Reusable and/or Disposable multi-angle biopsy kits
CnTI™: The use of Contrast Agents in the USA is limited by FDA to the Left Ventricle opacification and visualization of the Left ventricle endocardial border.
Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries. Product images are for illustrative purposes only. For further details, please contact your Esaote sales representative.
MyLab™Eight: The New Flasgship Platform in Esaote's Ultrasound Portfolio
You can download the ESAOTE LIBRARY APP iOS/Android in PlayStore/AppleStore on your personal tablet. A FREE registration to Esaote Library is required.
Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries. Product images are for illustrative purposes only. For further details, please contact your Esaote sales representative.
MyLab™Eight eXP: MyWork, MyPatient, MySystem, MyLab
Discover Esaote’s MyLab™Eight Ultrasound Platform: the culmination of Esaote’s commitment to R&D in order to meet the increasing demands of modern healthcare in terms of outstanding image quality and ease of use.
MyLab™Eight eXP: a new standard in Image Quality for confident diagnosis
Esaote’s MyLab™Eight eXP and MyLab™Eight Ultrasound systems are the new flagship platform in its Ultrasound portfolio and represent the complete solution for the most demanding clinical activity.
MyLab™Eight eXP: MPowered eXPerience in Ultrasound
MyLab™Eight Platform represents for our customers a valuable solution in terms of premium diagnostic capabilities and clinical efficacy in order to respond effectively with a conscious value to healthcare needs.
Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries. Product images are for illustrative purposes only.
For further details, please contact your Esaote sales representative.